| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;116:1482-1487.)
© 2007 American Heart Association, Inc.
Heart Failure |
From the Cardiovascular Division (S.D.S., H.S., M.A.P), Department of Medicine, Brigham and Womens Hospital, Boston, Mass; University of Glasgow (J.J.V.M.), Glasgow, UK; AstraZeneca LP (E.L.M.), Wilmington, Del; Sahlgrenska University, Hospital/Östra (K.S.), Göteborg, Sweden; Duke University Medical Center, (C.G.), Durham, NC; Hamilton Health Sciences and McMaster University (S.Y.), Hamilton, Ontario, Canada; Cleveland Clinic Foundation (J.B.Y.), Cleveland, Ohio; and London School of Hygiene (S.P., J.D.), London, UK.
Correspondence to Scott D. Solomon, MD, Cardiovascular Division, Brigham and Womens Hospital, 75 Francis St, Boston, MA 02115. E-mail ssolomon{at}rics.bwh.harvard.edu
Received February 15, 2007; accepted July 10, 2007.
Background— Patients with chronic heart failure (HF) are at increased risk of both fatal and nonfatal major adverse cardiovascular events. We used data from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) trials to assess the influence of nonfatal hospitalizations for HF on subsequent mortality rates in a broad spectrum of HF patients.
Methods and Results— In the present study, 7599 patients with New York Heart Association class II to IV HF and reduced or preserved left ventricular ejection fraction were randomized to placebo or candesartan. We assessed the risk of death after discharge from a first hospitalization for HF using time-updated Cox proportional-hazards models on 7572 patients for whom discharge data were available. Of 7572 patients, 1455 (19%) had at least 1 HF hospitalization, and 586 of 1819 deaths occurred after discharge from an HF hospitalization. The mortality rate was increased after HF hospitalizations, even after adjustment for baseline predictors of death (hazard ratio, 3.15; 95% confidence interval, 2.83 to 3.50). Longer duration of HF hospitalization enhanced the risk of dying, as did repeat HF hospitalizations. Moreover, risk of death was highest within a month of discharge and then declined progressively over time, particularly for death resulting from HF progression and for sudden cardiac death. We observed a similar pattern of risk associated with all-cause hospitalization, although the magnitude was less than that with HF hospitalization.
Conclusions— In patients with chronic HF, the risk of death is greatest in the early period after discharge after a hospitalization for HF and is directly related to the duration and frequency of HF hospitalizations. These findings suggest a role for increased surveillance in the early postdischarge period of greatest vulnerability after an HF admission.
This article has been cited by other articles:
![]() |
G. Breithardt MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure Eur. Heart J., November 1, 2009; 30(21): 2551 - 2553. [Full Text] [PDF] |
||||
![]() |
S. M. Dunlay, M. M. Redfield, S. A. Weston, T. M. Therneau, K. Hall Long, N. D. Shah, and V. L. Roger Hospitalizations after heart failure diagnosis a community perspective. J. Am. Coll. Cardiol., October 27, 2009; 54(18): 1695 - 1702. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Setoguchi and L. W. Stevenson Hospitalizations in patients with heart failure: who and why. J. Am. Coll. Cardiol., October 27, 2009; 54(18): 1703 - 1705. [Full Text] [PDF] |
||||
![]() |
J. J.V. McMurray, C. B. Granger, J. Ostergren, S. Yusuf, M. A. Pfeffer, and K. Swedberg Dual Renin-Angiotensin system blockade in heart failure. J. Am. Coll. Cardiol., July 14, 2009; 54(3): 278 - 278. [Full Text] [PDF] |
||||
![]() |
E. K. Song, D. K. Moser, and T. A. Lennie Relationship of Depressive Symptoms to the Impact of Physical Symptoms on Functional Status in Women With Heart Failure Am. J. Crit. Care., July 1, 2009; 18(4): 348 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J. Am. Coll. Cardiol., April 14, 2009; 53(15): e1 - e90. [Full Text] [PDF] |
||||
![]() |
M. Jessup, W. T. Abraham, D. E. Casey, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. A. Konstam, D. M. Mancini, P. S. Rahko, M. A. Silver, et al. 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1343 - 1382. [Full Text] [PDF] |
||||
![]() |
2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, M. Jessup, W. T. Abraham, D. E. Casey, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. A. Konstam, D. M. Mancini, P. S. Rahko, et al. 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation Circulation, April 14, 2009; 119(14): 1977 - 2016. [Full Text] [PDF] |
||||
![]() |
2005 WRITING COMMITTEE MEMBERS, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation Circulation, April 14, 2009; 119(14): e391 - e479. [Full Text] [PDF] |
||||
![]() |
M. Gheorghiade and P. S. Pang Acute heart failure syndromes. J. Am. Coll. Cardiol., February 17, 2009; 53(7): 557 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Abrahamsson, J. Dobson, C. B. Granger, J. J.V. McMurray, E. L. Michelson, M. Pfeffer, S. Pocock, S. D. Solomon, S. Yusuf, K. Swedberg, et al. Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure Eur. Heart J., February 1, 2009; 30(3): 338 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Flaherty, J. J. Bax, L. De Luca, J. S. Rossi, C. J. Davidson, G. Filippatos, P. P. Liu, M. A. Konstam, B. Greenberg, M. R. Mehra, et al. Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. J. Am. Coll. Cardiol., January 20, 2009; 53(3): 254 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ezekowitz, P. Kaul, J. A. Bakal, P. W. Armstrong, R. C. Welsh, and F. A. McAlister Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J. Am. Coll. Cardiol., January 6, 2009; 53(1): 13 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. McMurray, M. Petrie, K. Swedberg, M. Komajda, S. Anker, and R. Gardner CHAPTER 23 Heart Failure ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E.A. Blair, F. Zannad, M. A. Konstam, T. Cook, B. Traver, J. C. Burnett Jr, L. Grinfeld, H. Krasa, A. P. Maggioni, C. Orlandi, et al. Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure: Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program J. Am. Coll. Cardiol., November 11, 2008; 52(20): 1640 - 1648. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Arya, M. Block, J. Kautzner, T. Lewalter, H. Mortel, S. Sack, B. Schumacher, P. Sogaard, M. Taborsky, D. Husser, et al. Influence of Home Monitoring on the clinical status of heart failure patients: Design and rationale of the IN-TIME study Eur J Heart Fail, November 1, 2008; 10(11): 1143 - 1148. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gheorghiade, N. C. Wang, and T. Cook QRS Duration in Patients Hospitalized for Worsening Heart Failure--Reply JAMA, October 22, 2008; 300(16): 1880 - 1881. [Full Text] [PDF] |
||||
![]() |
F. Braunschweig, I. Ford, V. Conraads, M. R. Cowie, G. Jondeau, J. Kautzner, M. Lunati, R. M. Aguilera, C. M. Yu, M. Marijianowski, et al. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF) Eur J Heart Fail, September 1, 2008; 10(9): 907 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Butler and A. Kalogeropoulos Worsening Heart Failure Hospitalization Epidemic: We Do Not Know How to Prevent and We Do Not Know How to Treat! J. Am. Coll. Cardiol., August 5, 2008; 52(6): 435 - 437. [Full Text] [PDF] |
||||
![]() |
W. T. Abraham, G. C. Fonarow, N. M. Albert, W. G. Stough, M. Gheorghiade, B. H. Greenberg, C. M. O'Connor, J. L. Sun, C. W. Yancy, J. B. Young, et al. Predictors of In-Hospital Mortality in Patients Hospitalized for Heart Failure: Insights From the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) J. Am. Coll. Cardiol., July 29, 2008; 52(5): 347 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hoglund and L. A. F. Nilsson Letter by Hoglund and Nilsson Regarding Article, "Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure" Circulation, July 1, 2008; 118(1): e7 - e7. [Full Text] [PDF] |
||||
![]() |
S. D. Solomon, M. A. Pfeffer, S. Pocock, J. Marro, J. J.V. McMurray, C. B. Granger, S. Yusuf, K. Swedberg, J. B. Young, E. Michelson, et al. Response to Letter Regarding Article, "Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure" Circulation, July 1, 2008; 118(1): e8 - e8. [Full Text] [PDF] |
||||
![]() |
N. C. Wang, A. P. Maggioni, M. A. Konstam, F. Zannad, H. B. Krasa, J. C. Burnett Jr, L. Grinfeld, K. Swedberg, J. E. Udelson, T. Cook, et al. Clinical Implications of QRS Duration in Patients Hospitalized With Worsening Heart Failure and Reduced Left Ventricular Ejection Fraction JAMA, June 11, 2008; 299(22): 2656 - 2666. [Abstract] [Full Text] [PDF] |
||||
![]() |
Heart Failure Hospitalizations and Mortality Journal Watch Cardiology, October 17, 2007; 2007(1017): 4 - 4. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |